Didanosine; 2',3'-dideoxyinosine; 9-(2,3-Dideoxy-beta-d-glycero-pentofuranosyl)-1,9-dihydro-6H-purin-6-one

名称与同义词

• didanosine
• 2',3'-Dideoxyinosine
• DIDEOXYINOSINE
• Videx
• Didanosinum
• 69655-05-6
• Didanosina
• Videx EC
• ddIno
• Inosine, 2',3'-dideoxy-
• 2,3-dideoxyinosine
• (-)-didanosine
• Hypoxanthine ddN
• ddI (Antiviral)
• Didanosine EC
• Didanosine RS
• Didanosine CRS
• Didanosine(DD)
• Videx(TM)
• Intron A & Videx
• Videx EC;Videx
• 3'-dideoxyinosine
• Videx-EC
• Videx (TN)
• PC-SOD+ddI
• Didanosine (DDI)
• Dideoxyinosine (DDI)
• Didanosine (Videx)
• Didanosinum [INN-Latin]
• DdI & IFN-alpha
• LOA & ddI
• 2',3' Dideoxyinosine
• Didanosina [INN-Spanish]
• BMY-40900
• ddI & GM-CSF
• DDI and rIFN.alpha.2
• Didanosine (Standard)
• 2', 3'-dideoxyinosine
• Videx EC (TN)
• K3GDH6OH08
• 2',3'-didesoxyinosin
• ddI & sCD4(rsCD4)
• 2',5'-Dideoxyinosine
• 2'3'-DIDEOXYINOSINE
• ddI & IFN-.alpha.
• ddI + d4T combination
• DIDANOSINE [MI]
• RefChem:55012
• UNII-K3GDH6OH08
• DTXSID6022927
• DIDANOSINE [INN]
• DIDANOSINE [JAN]
• DIDANOSINE [HSDB]
• DIDANOSINE [USAN]
• NSC-612049
• CCRIS 805
• DIDANOSINE [VANDF]
• D06FDR
• D0P6OM
• Epitope ID:768739
• AC1L19ET
• DIDANOSINE [MART.]
• SCHEMBL3363
• SCHEMBL3364
• SCHEMBL3365
• BXZVVICBKDXVGW-NKWVEPMBSA-N
• CHEBI:490877
• DTXCID402927
• NSC 612049
• 2',3'-Dideoxy-D-inosine
• CHEMBL1460
• DIDANOSINE [USP-RS]
• DIDANOSINE [WHO-DD]
• DIDANOSINE [WHO-IP]
• DS-4152 & ddI
• BMY 40900
• Didanosine (JAN/USP/INN)
• Inosina, 2',3'-dideoxi-
• DRG-0016
• HSDB 6548
• MLS000759469
• MLS001055350
• MLS001424118
• MLS002154216
• MLS006011561
• Didanosine (JAN/USAN/INN)
• Didanosine [USAN:BAN:INN]
• Didanosine [USAN:INN:BAN]
• 2 ,3 -Dideoxyinosine
• Didanosine system suitability mixture
• MFCD00077728
• NSC612049
• 2',3'-Dideoxyinosine (ddI)
• C10H12N4O3
• DDI
• Didanosine [USAN:USP:INN:BAN]
• GTPL4833
• INO001
• orb1305302
• SCHEMBL7866996
• DIDANOSINE [EP IMPURITY]
• DIDANOSINE [ORANGE BOOK]
• SCHEMBL29387997
• Didanosine for system suitability
• HY-B0249R
• KS-00000FVB
• BRN 3619529
• DIDANOSINE [EP MONOGRAPH]
• DIDANOSINE [USP IMPURITY]
• Didanosine and Interferon-.alpha.-2
• J05AF02
• Videx EC(TM)(slow-release capsules)
• DIDANOSINE [USP MONOGRAPH]
• GLXC-08098
• HMS2051J11
• HMS2089N20
• HMS2095O08
• HMS2232P22
• HMS3712O08
• HMS3884M06
• DIDANOSINUM [WHO-IP LATIN]
• CID50599
• HY-B0249
• KS-1049
• Didanosine for system suitability RS
• Tox21_111732
• Tox21_202333
• Tox21_300575
• ANW-35738
• BDBM50404252
• EBC-13588
• EBC-26267
• EBC-44229
• NCGC00090691-03
• NCGC00159514-02
• ZINC13597823
• Didanosine for system suitability CRS
• 2',3'-Dideoxyinosine (AIDS Initiative)
• 2',3'-DIDEOXYINOSINE; Didanosine
• AKOS015833088
• AKOS015901454
• AKOS015963259
• AKOS026750545
• C10-H12-N4-O3
• Didanosine 100 microg/mL in Acetonitrile
• Tox21_111732_1
• CCG-100947
• CCG-220153
• CS-2229
• CS-O-01310
• DB00900
• NC00197
• ND02929
• RTR-030612
• SRI-7013-04
• SRI-7013-05
• SRI-7013_07
• 2-Deamino-2 ,3 -dideoxyguanosine
• NCGC00090691-01
• NCGC00090691-02
• NCGC00090691-14
• NCGC00159514-03
• NCGC00159514-04
• NCGC00164280-01
• NCGC00188983-01
• NCGC00254496-01
• NCGC00259882-01
• NCGC00390773-01
• 2',3'-Dideoxyinosine & Interferon-alpha
• AC-12026
• AC-32186
• AJ-64234
• AN-37869
• BC203896
• BP-58651
• CJ-14439
• CPD000058576
• K166
• SAM001246673
• SC-58339
• SID:92729668
• SMR000058576
• SMR004703324
• 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine
• 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
• CID:135398739
• 2',3'-Dideoxyinosine, >=98% (HPLC)
• AB0014064
• AB0069772
• AB2000230
• CAS-69655-05-6
• J261.930J
• TR-030612
• 2',3'-Dideoxyinosine & Interferon-.alpha.
• 9-(2,3-Dideoxy-beta-D-ribofuranosyl)hypoxanthine
• A8410
• D3066
• Listera ovata agglutinin & 2',3'-Dideoxyinosine
• NS00000541
• S1702
• SW198619-2
• C06953
• D00296
• EN300-123032
• J10315
• T71244
• 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol
• 9-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6,9-DIHYDRO-1H-PURIN-6-ONE
• 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
• 655D056
• 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one
• A836585
• D016049
• F326235
• Q422606
• SR-05000001487
• 2',3'-Dideoxyinosine & sCD4(soluble recombinant protein)
• 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one
• SR-05000001487-1
• SR-05000001487-2
• 3'-Azido-3'-deoxythymidine + 2',3'-Dideoxyinosine
• 9-(2,3-Dideoxy-beta-D-xylofuranosyl)-9H-purin-6-ol
• 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE
• 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
• BRD-K99063460-001-12-3
• BRD-K99063460-001-13-1
• DIDANOSINE SYSTEM SUITABILITY MIXTURE [USP-RS]
• 2',3'-dideoxyinosine, DDI, NSC 612049, Didanosine
• Z1546616193
• 9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol
• 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one
• Didanosine, European Pharmacopoeia (EP) Reference Standard
• Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine
• 2',3'-Dideoxyinosine & Granulocyte-macrophage colony-stimulating factor
• Didanosine, United States Pharmacopeia (USP) Reference Standard
• Inosine, 2',3'-dideoxy- & Recombinant Interferon-.alpha.-2
• Inosine, 2',3'-dideoxy-& Recombinant Interferon-.alpha.-2
• Lecithinized superoxide dismutase & Inosine, 2',3'-dideoxy-
• 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,9-dihydro-6H-purin-6-one
• 9-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6,9-DIHYDRO-3H-PURIN-6-ONE
• 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one
• 2 inverted exclamation mark ,3 inverted exclamation mark -Dideoxyinosine
• 2',3'-Dideoxyinosine, 98%, reverse transcriptase inhibitor - 100MG 100mg
• 2DI
• 9-((2R,5S)-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-3H-purin-6-one
• 9-[(2R,5S)-5-(Hydroxymethyl)oxolan-2-yl]-1,9-dihydro-6H-purin-6-one
• 9-[[(2R)-5beta-(Hydroxymethyl)tetrahydrofuran]-2beta-yl]-9H-purin-6-ol
• D2I
• 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one
• 9-((2R,5S)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-1H-PURIN-6(9H)-ONE
• Didanosine for system suitability, European Pharmacopoeia (EP) Reference Standard
• 2',3'-Dideoxy-1,9-dihydro-9-beta- D -ribofuranosyl-6 H -purin-6-one; 2',3'-Dideoxyinosine;
• 614-994-4
• 72448-59-0
• 882169-82-6
• Didanosine; 2',3'-dideoxyinosine; 9-(2,3-Dideoxy-beta-d-glycero-pentofuranosyl)-1,9-dihydro-6H-purin-6-one